Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players.

Share Article

Global genotyping market research helps established firms as well as new entrants / smaller firms them to gauge the pulse in industry for increasing their market shares – Available at RnRMarketResearch.com.

Market Research Reports

Market Research Reports

The global genotyping market with forecast to 2020. The global genotyping market is expected to reach $17.0 Billion in 2020 from $ 6.2 Billion in 2015, at a healthy CAGR of 22.3% from 2015 to 2020

The global genotyping market is expected to grow at a CAGR of 22.3% during the forecast period of 2015 to 2020 to reach $17.0billion in 2020. Genotyping tests are increasingly being used in drug discovery and development process and to provide personalized therapy, factors that are driving market growth. In addition to this,heavy investments by key manufacturers to offer advanced and innovative products for wider applications are also propelling market growth. Browse 113 market data tables & 37 figures spread through 200 pages and in-depth TOC on “Genotyping Market" at @ http://www.rnrmarketresearch.com/genotyping-market-by-technology-polymerase-chain-reaction-sequencing-microarray-electrophoresis-maldi_tof-application-pharmacogenomics-diagnostic-research-animal-genetics-agricultural-biote-market-report.html .
Based on application, the genotyping market market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping).The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The high growth in this segment is attributed to increasing use of genotyping in drug development process & to analyze the effects of drug.

Some prominent players in genotyping market include Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.). Various strategies such as collaborations, expansions, and new product launches helped these companies to maintain their market share and grow in this competitive market. Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=382108 .

Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms. The genotyping market is mainly driven by technological advancements, increasing incidence of genetic diseases and awareness on personalized medicine,decreasing prices of DNA sequencing, growing importance of SNP genotyping in drug development, and the growing demand for genotyping of animal and plant livestock. However, ambiguity inthe reimbursement for these products and a lack of well-trained lab technicians are drivers expected to restrain the growth of this market in the forecast period.

The genotyping market in this report is broadly segmented based on products and services, technology, applications, and endusers. The market, by technology, is segmented into microarrays, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, allele specific oligonucleotide (ASO) probes, and others (insitu hybridization). Sequencing market is forecasted to grow at a highest CAGR 27.7% over the forecast period of 2015-2020, owing to its high speed, accuracy, flexibility, and increasing application areas. Priced at $4650 for a single user PDF, a discount on “Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products – Global Forecast to 2020” research report can be requested at http://www.rnrmarketresearch.com/contacts/discount?rname=382108 .

Developed regions like North America and Europe will grow comparatively slower than emerging markets like Asia-Pacific and RoW (Latin America). Emerging countries are expected to record strong growth.Growth will be centered on countries like India, China, and Brazil owing to rising investments by public and private players in these countries, improving healthcare infrastructure, increase in the number of clinical research organizations and clinical trials in these countries, and the focus of leading players to capture growth opportunities in these markets.

The genotyping market report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

For more inquire @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=382108

Related Market Reports:

"Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) – Forecast to 2019” Companies profiled in this research report are Charles River Laboratories International, Inc, Sigma-Aldrich Corporation, SGS S.A, WUXI Pharmatech (Cayman), Inc, Merck & Co., Inc, Becton, Dickinson, and Company, North American Science Associates, Inc, Nelson Laboratories, Inc and Pacific Biolabs. discussed in this research available at http://www.rnrmarketresearch.com/bioburden-testing-market-by-product-instrument-pcr-microscopes-consumables-kit-reagent-test-aerobic-anaerobic-fungi-spore-application-raw-material-in-process-end-user-pharmaceu-market-report.html .

"Live Cell Imaging Market by Product (Equipment, Consumables, Software), Technology (Fluorescence Recovery after Photobleaching, High-Content Screening) & by Application (Cell Biology, Stem Cells, Drug Discovery) – Analysis & Global Forecast to 2019”. Companies profiled in this research report are Becton, Dickinson and Company, Carl Zeiss AG, Danaher Corporation, GE Healthcare, Molecular Devices, LLC, Nikon Corporation, Olympus Corporation, Perkinelmer, Inc, Sigma-Aldrich Corporation and Thermo Fisher Scientific, Inc are discussed in this research available at http://www.rnrmarketresearch.com/live-cell-imaging-market-by-product-equipment-consumables-software-technology-fluorescence-recovery-after-photobleaching-high-content-screening-by-application-cell-biology-stem-cells-drug-market-report.html .

Explore more Biotechnology Market Research Reports at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology .

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on
Visit website